Source: Manny Ramirez Suspension Linked to Sexual Enhancer

LOS ANGELES — Los Angeles Dodger outfielder Manny Ramirez is a surefire future Hall of Famer who’s always put up huge power numbers at the plate, but according to an anonymous source, it was his performance in the bedroom that was in need of a pick-me-up.

It was announced today by Major League Baseball that Ramirez tested positive for a banned substance and would be suspended for 50 games. Now, an anonymous source has come forward to tell Yahoo! Sports that the forbidden drug was used to treat the slugger’s sexual dysfunction.

Two other anonymous sources refute that claim and told Yahoo! that the substance Ramirez tested positive for was gonadotropin, which is most commonly used by women as a fertility drug. The drug also could be used to trigger testosterone production — the depletion of which is a side effect of steroids — but Ramirez has never tested positive for steroids or human growth hormone.

The banned drug is primarily used to stimulate the testicles — particularly for men with a history of steroid use.

“Testosterone and similar drugs are effective for erectile dysfunction in that they jazz up your sex drive,” Charles Yesalis, a professor at Penn State who has testified before Congress on issues of performance-enhancing drugs, told Yahoo! “But far more clinicians accept that affect with Viagra and Cialis. It’s hard for me to understand if it was erectile dysfunction why they would use it.”

Ramirez initially tested positive for the substance in spring training and then had another portion of the same sample tested again more recently.

A MLB official said Ramirez could have applied for a therapeutic exemption if he had a legitimate need for the drug, but Ramirez did not. Ramirez will not contest his suspension and will be out through July 3.

Ramirez’s suspension comes at a time when the Dodgers are undefeated at home and have baseball’s best record.

Related:  

Copyright © 2026 Adnet Media. All Rights Reserved. XBIZ is a trademark of Adnet Media.
Reproduction in whole or in part in any form or medium without express written permission is prohibited.

More News

Emma Rose Toplines 'TS Girls Do It Best 4' From TransSensual

Two-time XMAs Trans Performer of the Year Emma Rose headlines "TS Girls Do It Best 4," from Mile High Media studio imprint TransSensual.

Ofcom Investigates Pornhub's Device-Based UK Age Checks

U.K. media regulator Ofcom has opened an investigation to determine whether Pornhub parent company Aylo’s use of device-based age verification complies with the U.K.’s Online Safety Act.

Serenity Cox, Eva Angelina Star in Latest From MILFY

Serenity Cox and Eva Angelina star with Sheem in the latest release from Vixen Media Group studio imprint MILFY, titled "Yes Captain."

Lumi Ray, Blake Blossom & Isa Bella Star in Latest From Bellesa Plus

Lumi Ray, Blake Blossom, and Isa Bella star in the latest release from Bellesa Plus, titled "The Girl They Both Wanted."Directed by Jacky St. James, the scene opens with Ray, on her birthday weekend, being reunited with sorority sisters Blossom and Bella.

Maddie Wren, Chanel Camryn Star in 'My Lesbian Masseuse 2'

Maddie Wren and Chanel Camryn star in the second volume of "My Lesbian Masseuse," from Girlfriends Films.

'Studio Vanniall' Launches Through PAYSITE

Vanniall's official website StudioVanniall.com has launched through PAYSITE.

ERIKALUST Releases 'Squeaky Bed'

Venus Rey and Martin Grey star in the latest release from ERIKALUST, titled “Squeaky Bed,” directed by Rebecca Stewart.

Evil Angel Drops Proxy Paige's 'Gape Your Heart Out 3'

Evil Angel has released director Proxy Paige’s new title, “Gape Your Heart Out 3.”

France Weighs Ban on Purchase of 'Remote' Sexual Services

The French National Assembly is considering a proposal to criminalize the purchase, and/or facilitation by online platforms, of sexual services performed remotely by streamers and custom content creators.

YourVids Launches Customizable Subscription Feature for Creators

YourVids has rolled out YourFans, a service that allows creators to design customizable subscription tiers, from which they receive 100% of the revenue.

Show More